James Lehmann, MD
Ophthalmology · San Antonio, TXNPI 1861432114
Payments from drug & device makers
Across 351 payments — averaging $3055.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$613K
- Rxsight Inc$227K
- Glaukos Corporation$111K
- Avedro Inc.$83K
- AbbVie$19K
- Lensar, Inc.$16K
- plus $4K from 23 others
Across 28 payments — averaging $6093.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Rxsight Inc$171K
What the payments were for
- Consulting fees$20,95013%
- Speaking & faculty fees$123,89576%
- Food & beverage$9,5416%
- Gifts$2220%
- Other$7,4755%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 88 | $612,629 |
| Rxsight Inc | 50 | $226,658 |
| Glaukos Corporation | 82 | $111,140 |
| Avedro Inc. | 1 | $82,745 |
| AbbVie(2 entities) | 30 | $18,688 |
| Lensar, Inc. | 25 | $16,121 |
| Bausch & Lomb Americas Inc. | 4 | $1,940 |
| Alcon | 24 | $629 |
| Dompe US, Inc. | 6 | $338 |
| Novartis | 6 | $251 |
| Carl Zeiss Meditec USA, Inc. | 2 | $211 |
| Johnson & Johnson Vision Care, Inc. | 1 | $139 |
| Oyster Point Pharma, Inc. | 2 | $131 |
| NEW World Medical,inc. | 3 | $118 |
| Bausch Health US, LLC | 1 | $102 |
| Sun Pharmaceutical Industries Inc. | 3 | $95 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $91 |
| Eyevance Pharmaceuticals LLC | 4 | $76 |
| Biotissue Holdings Inc. | 2 | $51 |
| Omeros Corporation | 2 | $39 |
| Sight Sciences, Inc. | 2 | $34 |
| ABB Con-cise Optical Group LLC | 1 | $28 |
| Tarsus Pharmaceuticals, Inc. | 1 | $27 |
| Aerie Pharmaceuticals, Inc. | 1 | $19 |
| Harrow Eye, LLC | 1 | $19 |
| Optos, Inc. | 1 | $18 |
| Amgen | 1 | $16 |
| Ocular Therapeutix, Inc. | 1 | $14 |
| Kala Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RXSIGHT CONTACT LENS$113,830
- RXSIGHT INJECTOR CARTRIDGE$113,830
- RXSIGHT INJECTOR HANDPIECE$113,830
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$113,830
- LIGHT ADJUSTABLE LENS (LAL)$113,701
- LENSAR LASER SYSTEM$15,767
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$9,914
- Tecnis IOL$3,845
- Tecnis Symfony IOL$2,250
- Tecnis Multifocal Family of 1-piece IOLS$2,250
- Whitestar Phacoemulsficiation System$2,250
- XIIDRA$1,810
- Whitestar Signature$1,800
- MIEBO$1,700
- KXL System$1,543
- CE-marked KXLA system$1,177
- iDoseTR$518
- Photrexa Viscous and Photrexa$475
- VERITAS Vision System$364
- Tecnis Simplicity$256
How this compares
$1,072,381 in reported general payments places this provider in the 95th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 208 | $8,867 |
| Difluprednate | 43 | $3,809 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 41 | $2,027 |
| Bromfenac Sodium | 11 | $1,200 |
| ValacyclovirValacyclovir Hcl | 36 | $1,148 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 49 | $1,037 |
| Latanoprost | 42 | $447 |
| Tobramycin | 43 | $192 |
| ErythromycinErythromycin Base | 19 | $175 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in San Antonio
- Michael SingerSan Antonio$4.2M
- Gregory ParkhurstSan Antonio$4.1M
- Calvin MeinSan Antonio$1.3M
- Darren BellSan Antonio$906K
- Gregory BruninSan Antonio$709K
- Richard EvansSan Antonio$656K
- Edward RashidSan Antonio$523K
- Kenneth MaverickSan Antonio$485K
- Kundandeep NagiSan Antonio$442K
- Charles WykoffBellaire$73.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.